Skip to content

Continuous Deep Sedation Until Death

Continuous Deep Sedation Until Death Following a Decision to Limit or Stop Treatment in Intensive Care and in Continuous Surveillance Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05108792
Acronym
SPCMD-REA
Enrollment
585
Registered
2021-11-05
Start date
2021-02-26
Completion date
2021-10-01
Last updated
2021-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terminal Care

Keywords

Limit or Stop Treatment in Intensive Care, Continuous deep sedation (CDS), Continuous deep sedation until death (CDSUD)

Brief summary

This research is a descriptive observational study conducted in multicenter (intensive care and continuing care units) in France. All data collected is part of the patient record. The main objective is to describe the end-of-life sedative practices following a decision to limit or stop therapy in intensive care unit and continuing care unit.

Detailed description

All participating sites will include last 10 consecutive major patients deceased following a decision to limit or stop therapeutics. The study include only data from patients died before January 1, 2020. In the case report form the following information will be entered: * the characteristics of the unit of intensive care or continuing care unit. * Patient Characteristics * Characteristics of sedative practices

Interventions

OTHERNO INTERVENTION

observational study, no intervention performed

Sponsors

Société Française d'Anesthésie et de Réanimation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients at the time of death (\>18years) * Died in intensive care or in continuing care unit * Patient died before January 1st, 2020. * Patients deceased following a decision to limit or stop therapeutics

Exclusion criteria

* Patients who died of brain death or unexpected cardiac arrest at death of unsuccessful cardiopulmonary resuscitation * Patient who expressed during his lifetime his opposition to the use of his data for scientific research

Design outcomes

Primary

MeasureTime frameDescription
Description of end-of-life sedative practicesafter patient death (before january 1st 2020)Information concerning end-of-life sedative practices are recorder in the CRF (treatments used, patient's and unit characteristics...)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026